Metatron (MRNJ)
and Sanguine Biotech Finalize Projects For Bitcoin and Marijuana
focused Mobile Applications
DOVER, DE -- December 6th, 2017 -- InvestorsHub NewsWire
-- Metatron (OTC:
MRNJ), a technology pioneer specializing in the accelerated
release of over 2000 apps including Cannabis based, CBD, and
Vaporized secure chat apps via iTunes and Google Play, is pleased
to report the final stage development of Bitweed, a cryptocurrency
transaction and tracking app for Marijuana dispensaries and
consumers.
Sanguine Biotech has developed a network of 20,000 patients,
including 50+ patient advocacy group non-profits, biobanks, and
patient portals and now distributes the Metatron developed
Cannaboids app under its own iTunes account with Google Play soon
to follow.
The two companies plan to conduct a shared roll-out of mobile
applications geared to solve issues in the cannabis payment space
using Blockchain technology and Bitcoin options. These apps will be
marketed under Sanguine with Cannaboids (www.cannaboids.com), and Bitweed brands while Sanguine
(www.sanguinebio.com.) providing the necessary biotech
and medical research for Metatron (www.Metatroninc.com) app development.
"Using mobile technology to solve complex clinical trial
challenges and make lives better for patients is at the heart of
everything we do. We are passionate about empowering patients to
help advance medical research."
BRIAN NEMAN, CEO & CO-FOUNDER OF SANGUINE
Metatron (www.Metatroninc.com) recently signed a deal to
sell the Cannaboids app to Sanguine Biotech (www.sanguinebio.com.) and has an
on-going contract to integrate certain mobile technologies within
the app, more news about this agreement forthcoming. Here is a list
of their data and specimens used in 40+ peer-reviewed journal
articles.
"Bitcoin has been hitting record high
after record high this year and is about to be trading futures.
With Cannabis legal in about 29 states, and Canada making
recreational Marijuana legal, both industries are now becoming
mainstream. Payment solutions are needed for dispensaries and
customers so we plan on integrating the upcoming Bitweed and the
popular Cannaboids apps to make this process more efficient for
retailers and consumers We expect Bitweed to eventually evolve into
its own cryptocoin"" said CEO Joe Riehl
This announcement coincides with the launch of http://www.icocryptoblockchain.com, the premier
one-stop website soon to be app with the latest cryptocurrency
news, education, editorials, market capitalizations, trade volume
and ICO alerts.
Two exchanges, the CME and Cboe, are set to begin offering
bitcoin futures this month. Bitcoin's price rise as the launch of
bitcoin futures emerge will pave the way toward establishing the
digital currency as a legitimate asset class.
"This is a unique animal unlike any commodity we've looked at
before," said Andrew Busch, the CFTC's chief market intelligence
officer.
According to industry estimates, Bitcoin and the over 1000 other
cryptocoins are now worth over $300 billion, only a year ago they
were worth about 1 Billion. Today $10 billion+ in digital tokens
change hands daily and even big players such as Goldman Sachs,
Visa, Capital One, Nasdaq, and the New York Stock Exchange have
invested in blockchain technology.
According to Forbes By 2020, the Cannabis industry is expected
to create more jobs than manufacturing. Overall legal marijuana
sales are set to increase from about 7 billion dollars in 2016 to
26.5 billion dollars 2020. Since Canada recently legalized
recreational marijuana nationwide, it will result in an additional
23 Billion dollar added to the industry over the same time period
according to Delotte.
Metatron an industry leader in the field of mobile app
development with over 2000 apps created, millions in sales and
downloads historically, has partnered with high profile companies
and clients worldwide and is poised to revolutionize the exploding
crypto and cannabis industries.
Through its app development division i-Mobilize, and as a
pioneer in emerging markets, Metatron was the first company to
release any Cannabis related apps on iTunes and has extensive
experience in processing payments through its Just Data Billing
division. Release date for the BitWeed app is expected first
quarter of next year.
Metatron is also pleased to announce a formal offer to
Buzzlink.com, a cannabis e-commerce platform for dispensaries and
other retailers. Buzzlink.com will be financed partially by the
issuance of preferred B series shares.
Metatron approved investors can acquire Series B shares in
blocks of various sizes. The first round investors will receive the
highest discount. Series B shares can be redeemed through the
Company, are immune to reverse splits, and will convert at 1 B
share to 50,000 common shares at a discount. There are a limited
number of B shares available and Metatron reserves the right to end
offering at any time.
Details available at:
http://metatroninc.com/series-b/
Metatron's Apps:
iTunes: https://itunes.apple.com/us/artist/i-mobilize-inc./id325075390
Google Play: https://play.google.com/store/apps/developer?id=Metatron+Inc
Facebook: http://www.facebook.com/metatroninc
Twitter: http://twitter.com/metatroninc
News: http://metatroninc.com/blog
Forward-Looking Statements:
Any statements made in this press release which are not
historical facts contain certain forward-looking statements, as
such term is defined in the Private Litigation Reform Act of 1995,
concerning potential developments affecting the business,
prospects, financial condition and other aspects of the company to
which this release pertains. These forward-looking statements
involve known and unknown risks, uncertainties and other factors
that may cause our actual results of the specific items described
in this release, and the company's operations generally, to differ
materially from what is projected in such forward-looking
statements. Although such statements are based upon the best
judgments of management of the company as of the date of this
release, significant deviations in magnitude, timing and other
factors may result from business risks and uncertainties including,
without limitation, the company's need for additional financing,
which is not assured and which may result in dilution of
shareholders, the company's status as a small company with a
limited operating history, dependence on third parties and the
continuing popularity of the iOS operating system, general market
and economic conditions, technical factors, receipt of revenues,
and other factors, many of which are beyond the control of the
company. Although we believe that the expectations reflected in the
forward-looking statements are reasonable, we cannot guarantee
future results, levels of activity, performance, or achievements.
Moreover, neither we nor any other person assumes responsibility
for the accuracy and completeness of such statements, and we
disclaim any obligation to update information contained in any
forward-looking statement. Metatron does not grow, sell or
distribute any substances that violate United States Law or the
Controlled Substances Act.
Metatron, Inc.
302-861-0431
ir@metatroninc.com
SOURCE: Metatron, Inc
